QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.108.053702v1 75/5/1005    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by DeKeyser, J. G. Articles by Omiecinski, C. J. Search for Related Content PubMed PubMed Citation Articles by DeKeyser, J. G. Articles by Omiecinski, C. J.

Accelerated Communication

Di(2-ethylhexyl) phthalate Is a Highly Potent Agonist for the Human Constitutive Androstane Receptor Splice Variant CAR2

Center for Molecular Toxicology and Carcinogenesis, Department of Veterinary and Biomedical Sciences (J.G.D., K.S.P., C.J.O.), and Department of Chemistry (M.C.S), the Pennsylvania State University, University Park, Pennsylvania; Departments of Biochemistry & Molecular Biology (M.C.S., A.D.J.), and Chemistry (A.D.J.), Michigan State University, East Lansing, Michigan; and National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina (S.S.A.)

The human constitutive androstane receptor (CAR, CAR1) regulates the expression of genes involved in xenobiotic metabolism in the liver. The CAR gene uses multiple alternative splicing events during pre-mRNA processing, thereby enhancing the CAR transcriptome. Previous reports have identified two prominent human CAR variants, CAR2 and CAR3, that possess four- and five-amino acid insertions in their ligand binding domains, respectively. Unlike the constitutively active reference form of the receptor, we now demonstrate that CAR2 is a ligand-activated receptor and comprises approximately 30% of the reference transcript level in human liver tissues in human hepatocytes. Furthermore, we identify the common plasticizer, di(2-ethylhexyl) phthalate (DEHP), as a highly potent and uniquely selective agonist of CAR2. Results from reporter transactivation and mammalian two-hybrid assays reveal that DEHP activates CAR2 at low nanomolar concentrations, results further supported by analysis of CAR target gene expression in primary human hepatocytes. In addition, comparative genomic analyses show that the typical mouse, rat, and marmoset models of DEHP toxicity cannot accurately profile potential human toxicity because of these species' inability to generate a CAR2-like transcript. The discovery that CAR2 is an ultimate human DEHP receptor identifies a novel pathway modulating human DEHP toxicity with potential clinical implications for a subset of patients undergoing critical care medical interventions.

Received for publication November 25, 2008.

Accepted for publication February 5, 2009.

Address correspondence to: Dr. Curtis J. Omiecinski, Center for Molecular Toxicology and Carcinogenesis, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802. E-mail: cjo10{at}psu.edu